Next on tap for Meridian Bioscience‘s (NASDAQ:VIVO) illumigene molecular diagnostic testing platform is a test for Mycoplasma pneumonia, an infection of the lungs. The illumigene Mycoplasma test is ...

CINCINNATI, Ohio — Meridian Bioscience’s European division will distribute in Italy a test for intestinal problems with plans to expand into France. The test, Quantum Blue Calprotectin, differentiates ...

Meridian Bioscience, Inc. announced that it has received the CE Mark for illumigene Malaria, a novel, highly accurate test developed by Meridian with the technical assistance of the Centers for ...

(Reuters) - Meridian Bioscience Inc said its test to detect a common bacterial throat infection received marketing approval in the United States. Meridian said its molecular test can detect Group A ...